Azor
These highlights do not include all the information needed to use AZOR safely and effectively. See full prescribing information for AZOR . AZOR (amlodipine and olmesartan medoxomil) tablets , for oral use Initial U.S. Approval: 200 7
f48911e0-705f-11dc-afc9-0002a5d5c51b
HUMAN PRESCRIPTION DRUG LABEL
Jun 7, 2022
Daiichi Sankyo Inc.
DUNS: 068605067
Products 4
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
amlodipine besylate and olmesartan medoxomil
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (10)
amlodipine besylate and olmesartan medoxomil
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (13)
amlodipine besylate and olmesartan medoxomil
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (12)
amlodipine besylate and olmesartan medoxomil
Product Details
FDA regulatory identification and product classification information